A non‐enzymatic function of 17β‐hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival
Open Access
- 4 February 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 2 (2), 51-62
- https://doi.org/10.1002/emmm.200900055
Abstract
Deficiency of the mitochondrial enzyme 2‐methyl‐3‐hydroxybutyryl‐CoA dehydrogenase involved in isoleucine metabolism causes an organic aciduria with atypical neurodegenerative course. The disease‐causing gene is HSD17B10 and encodes 17β‐hydroxysteroid dehydrogenase type 10 (HSD10), a protein also implicated in the pathogenesis of Alzheimer9s disease. Here we show that clinical symptoms in patients are not correlated with residual enzymatic activity of mutated HSD10. Loss‐of‐function and rescue experiments in Xenopus embryos and cells derived from conditional Hsd17b10−/− mice demonstrate that a property of HSD10 independent of its enzymatic activity is essential for structural and functional integrity of mitochondria. Impairment of this function in neural cells causes apoptotic cell death whilst the enzymatic activity of HSD10 is not required for cell survival. This finding indicates that the symptoms in patients with mutations in the HSD17B10 gene are unrelated to accumulation of toxic metabolites in the isoleucine pathway and, rather, related to defects in general mitochondrial function. Therefore alternative therapeutic approaches to an isoleucine‐restricted diet are required.Keywords
This publication has 15 references indexed in Scilit:
- Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- The Reduced Expression of the HADH2 Protein Causes X-Linked Mental Retardation, Choreoathetosis, and Abnormal BehaviorAmerican Journal of Human Genetics, 2007
- Target-dependent specification of the neurotransmitter phenotype:cholinergic differentiation of sympathetic neurons is mediated in vivo by gp130 signalingDevelopment, 2006
- L‐3‐hydroxyacyl‐CoA dehydrogenase II protects in a model of Parkinson's diseaseAnnals of Neurology, 2004
- ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's DiseaseScience, 2004
- Expanded substrate screenings of human and Drosophila type 10 17β-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3α/7α/7β/17β/20β/21-HSDBiochemical Journal, 2003
- 2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency Is Caused by Mutations in the HADH2 GeneAmerican Journal of Human Genetics, 2003
- Progressive Infantile Neurodegeneration Caused by 2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency: A Novel Inborn Error of Branched-Chain Fatty Acid and Isoleucine MetabolismPediatric Research, 2000
- Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid β-peptideBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- A SIMPLIFIED LEAD CITRATE STAIN FOR USE IN ELECTRON MICROSCOPYThe Journal of cell biology, 1965